Literature DB >> 12004057

Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme.

Marta Toth1, Sonia Hernandez-Barrantes, Pamela Osenkowski, M Margarida Bernardo, David C Gervasi, Yoichiro Shimura, Oussama Meroueh, Lakshmi P Kotra, Beatriz G Gálvez, Alicia G Arroyo, Shahriar Mobashery, Rafael Fridman.   

Abstract

Membrane type 1 matrix metalloproteinase (MT1-MMP) is a type I transmembrane MMP shown to play a critical role in normal development and in malignant processes. Emerging evidence indicates that MT1-MMP is regulated by a process of ectodomain shedding. Active MT1-MMP undergoes autocatalytic processing on the cell surface, leading to the formation of an inactive 44-kDa fragment and release of the entire catalytic domain. Analysis of the released MT1-MMP forms in various cell types revealed a complex pattern of shedding involving two major fragments of 50 and 18 kDa and two minor species of 56 and 31-35 kDa. Protease inhibitor studies and a catalytically inactive MT1-MMP mutant revealed both autocatalytic (18 kDa) and non-autocatalytic (56, 50, and 31-35 kDa) shedding mechanisms. Purification and sequencing of the 18-kDa fragment indicated that it extends from Tyr(112) to Ala(255). Structural and sequencing data indicate that shedding of the 18-kDa fragment is initiated at the Gly(284)-Gly(285) site, followed by cleavage between the conserved Ala(255) and Ile(256) residues near the conserved methionine turn, a structural feature of the catalytic domain of all MMPs. Consistently, a recombinant 18-kDa fragment had no catalytic activity and did not bind TIMP-2. Thus, autocatalytic shedding evolved as a specific mechanism to terminate MT1-MMP activity on the cell surface by disrupting enzyme integrity at a vital structural site. In contrast, functional data suggest that the non-autocatalytic shedding generates soluble active MT1-MMP species capable of binding TIMP-2. These studies suggest that ectodomain shedding regulates the pericellular and extracellular activities of MT1-MMP through a delicate balance of active and inactive enzyme-soluble fragments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004057     DOI: 10.1074/jbc.M200655200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Mechanical control of spheroid growth: distinct morphogenetic regimes.

Authors:  Oswaldo A Lozoya; Sharon R Lubkin
Journal:  J Biomech       Date:  2011-12-06       Impact factor: 2.712

Review 2.  Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy.

Authors:  Alejandro Majali-Martinez; Ursula Hiden; Nassim Ghaffari-Tabrizi-Wizsy; Uwe Lang; Gernot Desoye; Martina Dieber-Rotheneder
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

3.  Development of a solid-phase assay for analysis of matrix metalloproteinase activity.

Authors:  Janelle L Lauer-Fields; Hideaki Nagase; Gregg B Fields
Journal:  J Biomol Tech       Date:  2004-12

4.  Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases.

Authors:  Hsueh-Liang Fu; Anjum Sohail; Rajeshwari R Valiathan; Benjamin D Wasinski; Malika Kumarasiri; Kiran V Mahasenan; M Margarida Bernardo; Dorota Tokmina-Roszyk; Gregg B Fields; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

5.  The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase.

Authors:  Thomas Ludwig; Sarah M Theissen; Michael J Morton; Michael J Caplan
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  Characterization and regulation of MT1-MMP cell surface-associated activity.

Authors:  Sonia Pahwa; Manishabrata Bhowmick; Sabrina Amar; Jian Cao; Alex Y Strongin; Rafael Fridman; Stephen J Weiss; Gregg B Fields
Journal:  Chem Biol Drug Des       Date:  2018-12-19       Impact factor: 2.817

7.  The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts.

Authors:  Teresina Laragione; Max Brenner; Adriana Mello; Marc Symons; Pércio S Gulko
Journal:  Arthritis Rheum       Date:  2008-08

8.  Potential role for ADAM15 in pathological neovascularization in mice.

Authors:  Keisuke Horiuchi; Gisela Weskamp; Lawrence Lum; Hans-Peter Hammes; Hui Cai; Thomas A Brodie; Thomas Ludwig; Riccardo Chiusaroli; Roland Baron; Klaus T Preissner; Katia Manova; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface.

Authors:  Yoshifumi Itoh; Noriko Ito; Hideaki Nagase; Motoharu Seiki
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

10.  Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis.

Authors:  Benson C Lu; Cristina Cebrian; Xuan Chi; Satu Kuure; Richard Kuo; Carlton M Bates; Silvia Arber; John Hassell; Lesley MacNeil; Masato Hoshi; Sanjay Jain; Naoya Asai; Masahide Takahashi; Kai M Schmidt-Ott; Jonathan Barasch; Vivette D'Agati; Frank Costantini
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.